Viewing Study NCT02982395


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2025-12-30 @ 3:20 AM
Study NCT ID: NCT02982395
Status: TERMINATED
Last Update Posted: 2019-08-30
First Post: 2016-11-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC
Sponsor: Samyang Biopharmaceuticals Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module